These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 25244301)
1. Corneal and conjunctival sensitivity changes following intravitreal ranibizumab injection in diabetic retinopathy. Örnek N; Örnek K; Erbahçeci İE J Ocul Pharmacol Ther; 2015 Feb; 31(1):37-42. PubMed ID: 25244301 [TBL] [Abstract][Full Text] [Related]
2. Diameter of retinal vessels in patients with diabetic macular edema is not altered by intravitreal ranibizumab (lucentis). Terai N; Haustein M; Siegel A; Stodtmeister R; Pillunat LE; Sandner D Retina; 2014 Jul; 34(7):1466-72. PubMed ID: 24457978 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic macular edema. Rauen PI; Ribeiro JA; Almeida FP; Scott IU; Messias A; Jorge R Retina; 2012 Oct; 32(9):1799-803. PubMed ID: 22495327 [TBL] [Abstract][Full Text] [Related]
4. Improvement of diabetic retinopathy with intravitreal Ranibizumab. Kernt M; Cserhati S; Seidensticker F; Liegl R; Kampik A; Neubauer A; Ulbig MW; Reznicek L Diabetes Res Clin Pract; 2013 Apr; 100(1):e11-3. PubMed ID: 23391744 [TBL] [Abstract][Full Text] [Related]
5. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment. Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578 [TBL] [Abstract][Full Text] [Related]
6. Resolution of diabetic papillopathy after a single intravitreal injection of ranibizumab. Willerslev A; Munch IC; Larsen M Acta Ophthalmol; 2012 Aug; 90(5):e407-9. PubMed ID: 22268957 [No Abstract] [Full Text] [Related]
7. Short-term fluctuation of diabetic macular edema after intravitreal ranibizumab injection. Querques G; Bux AV; Martinelli D; Iaculli C; Del Curatolo MV; Delle Noci N Retina; 2009 Oct; 29(9):1274-81. PubMed ID: 19696699 [TBL] [Abstract][Full Text] [Related]
8. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy. Filho JA; Messias A; Almeida FP; Ribeiro JA; Costa RA; Scott IU; Jorge R Acta Ophthalmol; 2011 Nov; 89(7):e567-72. PubMed ID: 21726427 [TBL] [Abstract][Full Text] [Related]
9. Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema. Ozturk BT; Kerimoglu H; Bozkurt B; Okudan S J Ocul Pharmacol Ther; 2011 Aug; 27(4):373-7. PubMed ID: 21631366 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema. Solaiman KA; Diab MM; Abo-Elenin M Retina; 2010; 30(10):1638-45. PubMed ID: 20838357 [TBL] [Abstract][Full Text] [Related]
11. Spectral domain optical coherence tomography predictors of visual outcome in diabetic cystoid macular edema after bevacizumab injection. Al Faran A; Mousa A; Al Shamsi H; Al Gaeed A; Ghazi NG Retina; 2014 Jun; 34(6):1208-15. PubMed ID: 24368308 [TBL] [Abstract][Full Text] [Related]
12. Long-term effects of ranibizumab on diabetic retinopathy severity and progression. Ip MS; Domalpally A; Hopkins JJ; Wong P; Ehrlich JS Arch Ophthalmol; 2012 Sep; 130(9):1145-52. PubMed ID: 22965590 [TBL] [Abstract][Full Text] [Related]
13. Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study. Isaac DL; Abud MB; Frantz KA; Rassi AR; Avila M Acta Ophthalmol; 2012 Feb; 90(1):56-60. PubMed ID: 20015098 [TBL] [Abstract][Full Text] [Related]
14. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Nguyen QD; Brown DM; Marcus DM; Boyer DS; Patel S; Feiner L; Gibson A; Sy J; Rundle AC; Hopkins JJ; Rubio RG; Ehrlich JS; Ophthalmology; 2012 Apr; 119(4):789-801. PubMed ID: 22330964 [TBL] [Abstract][Full Text] [Related]
15. Microaneurysm turnover in diabetic retinopathy assessed by automated RetmarkerDR image analysis--potential role as biomarker of response to ranibizumab treatment. Leicht SF; Kernt M; Neubauer A; Wolf A; Oliveira CM; Ulbig M; Haritoglou C Ophthalmologica; 2014; 231(4):198-203. PubMed ID: 24662930 [TBL] [Abstract][Full Text] [Related]
16. The effect and safety of intravitreal injection of ranibizumab and bevacizumab on the corneal endothelium in the treatment of diabetic macular edema. Guzel H; Bakbak B; Koylu MT; Gonul S; Ozturk B; Gedik S Cutan Ocul Toxicol; 2017 Mar; 36(1):5-8. PubMed ID: 26911396 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A Retina; 2006; 26(9):999-1005. PubMed ID: 17151486 [TBL] [Abstract][Full Text] [Related]
18. Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy. Chae JB; Joe SG; Yang SJ; Lee JY; Sung KR; Kim JY; Kim JG; Yoon YH Retina; 2014 Jan; 34(1):149-56. PubMed ID: 23807186 [TBL] [Abstract][Full Text] [Related]
19. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710 [TBL] [Abstract][Full Text] [Related]